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Background: The role of hypertension in the loss of cognitive function is controversial. Relationships between
hypertension and increases in cerebral vascular resistance, diffused lesions and multiple lacunar infarcts of the white
matter are well known. Thus, the objectives of this study were: to evaluate the relationship between hypertension
and cognitive dysfunction (CD), identify risk factors and determine the association between early markers of
vascular disease and CD in hypertensive individuals.
Methods: Two hundred individuals aged between 40 and 80 years old were evaluated in this cross-sectional
prospective study. Fifty participants were controls (CT). The remaining 150 hypertensive patients were subdivided
into two groups, those with CD (HCD) and those without CD (HNCD). All participants underwent clinical evaluations
and biochemical blood tests were performed. CD was investigated using the Mini Mental State Examination (MMSE)
following the guidelines for its use in Brazil. The impact of hypertension on the arterial bed was assessed by
identifying and measuring changes in the intima-media thickness (IMT) by vascular ultrasonography of the carotid
arteries and analyses of the central blood pressure and Augmentation Index by applanation tonometry of the
radial artery.
Results: There were no significant differences in the total cholesterol, high-density lipoprotein cholesterol and
triglycerides plasma concentrations between the three groups. The serum creatinine and estimated glomerular
filtration rate were within normal ranges for all three groups. A significantly lower MMSE score was recorded for the
HCD Group compared to the HNCD and CT Groups (p-value < 0.05).
The IMT was significantly different between the HNCD and HCD Groups (p-value = 0.0124). A significant difference
in the IMT was also observed between hypertensive patients and the CT Group (p-value < 0.0001). Age, low-density
cholesterol, high-density cholesterol, triglycerides and IMT increased the Odds Ratio for cognitive dysfunction.
The central systolic pressure was significantly higher in the HCD and HNCD Groups compared to CT Group
(p-value < 0.0001).
Conclusions: Hypertensive patients with CD have changes in the vascular morphology characterized by an
increased carotid IMT, enhanced atherosclerotic lipid profile and impaired hemodynamic functional manifested by
elevated central systolic blood pressure.
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Hypertension is a major risk factor for cardiovascular
disease including strokes (especially hemorrhagic), cor-
onary heart disease (myocardial infarction) [1-3], left
ventricular hypertrophy, congestive heart failure [4-6],
aortic dissection [7-9], renal failure [10-12] and periph-
eral vascular disease [13]. Acute myocardial infarction
and strokes are associated with high mortality rates in
adulthood, particularly in the elderly [14-16].
Cognitive deficiency (CD) is considered a form of de-
mentia and defined as a “persistent or permanent de-
cline in varying dimensions of intellectual function in a
way that it interferes with the individual’s normal social
or economic activities. Currently, the Diagnostic and
Statistical Manual of Mental Disorders defines dementia
as an ‘organic brain syndrome’ (American Psychiatric
Association, 1994); this is mainly to differentiate it from
other cognitive function disorders such as mental retard-
ation and reversible episodes of amnesia or other
changes in focal elements of cognitive components such
as language disorders[17,18].
The role of hypertension in determining the loss of
cognitive function is not well defined [19,20]. It is well
known that hypertension is associated to increased cere-
bral vascular resistance with diffuse lesions and multiple
lacunar infarcts in the white matter (especially in the
subcortical region) that are histopathologically detect-
able and visible by magnetic resonance imaging [21-23].
Such infarcts have been linked to dementia in the elderly
[24]. With the current scientific and technological pro-
gress, more accurate diagnostic tests such as positron
emission tomography allow a better understanding of
changes in human brain structures related to hyperten-
sion, as do animal experiments, which allow a histo-
pathological view of similar lesions [25-29]. Thus,
vascular risk factors may impair cognitive function and
are linked not only to vascular dementia but also to Alz-
heimer’s disease. The level of evidence for these associa-
tions is highest for hypertension and diabetes mellitus,
especially when these factors are found in middle-aged
individuals [30].
The effect of antihypertensive treatment on the cog-
nitive function in older adults is also controversial.
Some studies suggest that treatment improves cognitive
function while others found no effect or even the op-
posite effect [31-34]. In general, research has difficulty
in distinguishing the true influence of hypertension on
cognition as the effect of antihypertensive medications
must be taken into account [35-38]. This is because of
several reasons; in general, adequate blood pressure
(BP) control is not achieved with the treatment regi-
mens both due to non-adherence to treatment and due
to the inappropriate choice of antihypertensive medica-
tions. It is well known that hypertension should betreated with drug combinations when the desired effect
of a drop in BP is not attained with a single medication
[39,40].
Thus, the objectives of this study were to evaluate the
relationship between hypertension and CD, to identify
risk factors associated to the development of CD (gen-
der, age, education, body mass index (BMI), dyslipide-
mia, diabetes and chronic kidney disease) and to
determine associations between different early markers
of vascular disease (carotid intima-media thickness, vas-
cular elasticity and rigidity, and central arterial pressure)
and CD in hypertensive individuals on regular antihyper-
tensive treatment.
Patients and methods
The sample population of this prospective study con-
sisted of two hundred consecutive male and female indi-
viduals aged between 40 and 80 years old selected in the
specialized hypertension center of the Medicine School
in São José do Rio Preto (FAMERP). All participants
were submitted to ultrasound assessment and the Mini
Mental State Examination between February 2009 and
October 2011. Of these, one hundred and fifty were
stage II hypertensive patients according to JNC VII [39];
Forty-two hypertensive patients had CD (HCD group)
and one hundred and eight hypertensive patients had no
CD (HNCD group).
The Control Group (CT), made up of non-hyperten-
sive, non-cognitive dysfunction individuals, was selected
from subjects referred to investigate stage I primary
hypertension but whose blood pressures proved to be
normal after standard measurements in the physical
examination and whose biochemical blood tests were
normal.
This study was approved by the Research Ethics Com-
mittee of the Post Graduation Program in Health
Sciences of the Medicine School in São José do Rio
Preto (FAMERP). Informed written consent was
obtained from all participants before their enrollment in
the study. The sample size was estimated based on an
80% statistical power to demonstrate the objectives of
the study with a type I alpha error rate of 5%.
The inclusion criteria of the hypertensive patients
were: age between 40 and 80 years under treatment for
stage II hypertension - VII JNC, optimal response to
pharmacological treatment (BP < 140/90 mmHg) with no
acute medical illness in the previous month and the abil-
ity to understand, verbalize and answer questions related
to the study. The exclusion criteria were the presence of
atherosclerotic plaque defined as a focal structure that
encroaches into the arterial lumen by at least 0.5 mm or
50% of the surrounding IMT or demonstrates a thick-
ness > 1.5 mm as measured from the media-adventitia
interface to the intima-lumen interface.
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physical examinations and investigations of their family
history for cardiovascular disease. Blood pressure of the
right arm was measured during the morning by a trained
healthcare professional with the patient in the seated
position and using an appropriately sized cuff.
The age, gender, weight, height, and the results of an
electrocardiogram and biochemical blood tests were
recorded. Patients with secondary hypertension, those
taking anticholinesterase drugs, those that had suffered
strokes, had diagnosis of dementia or had recently had
an acute infection were excluded in order to rule out the
possibility of acute confusional state. Additionally,
patients with family history of Alzheimer’s disease (par-
ents and siblings), or history of psychiatric illness or sub-
stance abuse were excluded.Mini-mental state examination
The Mini-Mental State Examination (MMSE) is a test
that uses two specific types of responses, verbal and
nonverbal, to identify cases of CD. Diagnosis of demen-
tia or any specific dementing illness is not an objective
of this test. Responses to questions are studied through
verbal sub-tests that measure time-space orientation, im-
mediate memory, attention and calculation, and recall
and language and nonverbal subtests that assess
perceptual-motor coordination and comprehension of
instructions. The test quantifies responses through sim-
ple, easy to use criteria that are compatible with the ap-
plication. Administration of the test takes about 5 to
10 minutes by duly trained professionals. The test is
dependent on the level of education of the interviewee.
The MMSE results in a maximum score of 30 points
where the lower the score, the greater the CD with 24
points originally being considered as the cutoff point
[41-46].Blood pressure measurements
The starting point to evaluate hypertension is the accur-
acy of the BP measurement. The average of three mea-
surements of the systolic blood pressure (SBP) and
diastolic blood pressure (DBP) were recorded. Measure-
ments were made by the indirect technique using
OMRON equipment and employing cuffs with appropri-
ate dimensions for the perimeter of the arm (a width-
length ratio of 1:2). The readings were taken after the
patient had remained resting in the seated position with
the arm on a support at the same height as the apex in a
quiet environment for 5 to 15 minutes, at least 60 min-
utes after the ingestion of coffee and 30 minutes after
smoking. BP analyses were performed at least three
times with an interval of five minutes between readings
and the mean of measurements was calculated.Carotid intima-media thickness
The carotid intima-media thickness (IMT), the mean
thickness of the anterior and posterior walls of the left
and right carotid arteries, was evaluated using high reso-
lution ultrasound. Patients were always examined be-
tween 7:00 a.m. and 11:00 a.m. in the supine position
with the head at a 45° angle on a support.
This method is established and standardized according
to the “34th Report of the Bethesda Conference Task
Force #3 Noninvasive Atherosclerosis Measurement”
[47] using a sample protocol outlined by the American
Society of Echocardiography [48].
The ultrasound analysis was performed by a physician
experienced in vascular studies and certified by the Car-
diovascular Imaging Department of the Brazilian Society
of Cardiology and blinded to the patient's clinical data.
The examination was carried out according to a previ-
ously established protocol [49] standardized for both ca-
rotid arteries. Images were acquired at end diastole
(defined as the R wave of the electrocardiogram) using a
7–12 MHz linear transducer and high resolution ultra-
sound (Philips, HD 11 XE, Andover MA – USA). The
intima-media thickness was measured over a 1-cm seg-
ment of the artery located approximately 0.5 cm below
the carotid-artery bulb and considered not to contain
any plaque (i.e., not to have any perceivable protrusion
of the artery wall into the lumen) [50,51].
The IMT data were analyzed offline by two independ-
ent observers by computer program analysis (M’ATh -
Metris, France) which allows measurement of the IMT
from images obtained during four cardiac cycles identi-
fied by the R wave of the ECG. The analysis, based on
the tone of the gray scale and a specific algorithm to
recognize tissue, is automatic. The average measure-
ments of the near and far walls of the left and the right
common carotid arteries were used to compare the
results between the three study groups. The variability
between IMT measurements should be less than 2%, as
in this study.
Radial artery tonometry and central systolic blood
pressure
Central (aortic and carotid) blood pressures are more
strongly related to the pathogenesis of cardiovascular
disease than peripheral pressures [52]. It is the aortic
systolic pressure that the left ventricle encounters during
systole (afterload), and the aortic pressure during dia-
stole is a determinant of coronary perfusion. Further-
more, the distending pressure in the large elastic-type
arteries (aorta and carotid) is a key determinant of the
degenerative changes that characterize accelerated aging
and hypertension. In contrast, muscular peripheral arter-
ies, such as the brachial and radial arteries, are less influ-
enced by these changes [53].
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tral and peripheral arteries, it is inaccurate to use the
brachial pulse pressure as a surrogate for carotid or aor-
tic pulse pressure, particularly in young subjects. The ca-
rotid femoral Pulse Wave Velocity (PWV) is considered
the “gold standard” measurement of arterial stiffness.
Pulse-wave analysis should be obtained at the central
level, i.e. at the site of the carotid artery or the ascending
aorta, and either directly recorded or computed from
the radial artery waveform using a transfer function. The
pulse waveform should be analyzed by three major para-
meters: central pulse pressure, central systolic blood
pressure and augmentation index [54].
Arterial stiffness is one of the determinants of
increased pulse pressure (PP) and central BP, which are
considered predictors of cardiovascular risk.
Tonometry of the radial artery provides an accurate,
reproducible, noninvasive assessment of the central PP
waveform. Radial artery applanation tonometry (AT) is
performed by placing a hand-held tonometer (strain
gauge pressure sensor) over the radial artery and apply-
ing mild pressure to partially flatten the artery. The ra-
dial artery pressure is then transmitted from the vessel
to the sensor (strain gauge) and is recorded digitally. A
mathematical formula using a fast Fourier transform-
ation algorithm, approved by the Food and Drug Admin-
istration of the USA, permits derivation and calculation
of central systolic blood pressure indices from a periph-
eral brachial blood pressure with concomitant recording
of a PP wave with radial AT. This provides information
on the functional condition of arteries by the Augmenta-
tion Index, which calculates the ratio of the reflected
wave and the ejection wave [51]. The premise states that
the speed at which these waves travel increases as the ri-
gidity of the arterial wall increases. Thus, endothelial
disorders with reduced function can be detected early by
the AT system [55-58].
The examination to evaluate the AT was made with
the patient in a quiet environment, after resting for at
least 5 minutes, sitting with the legs uncrossed and the
bladder empty, away from acute stressors, without hav-
ing drunk alcoholic beverages and without having
smoked for at least 30 minutes. The OMROM AT
equipment with a radial ultrasound transducer was
employed with cuffs of suitable dimensions and correct
proportion for the arm circumference.
Statistical analysis
Descriptive statistics were performed to describe the
sample in relation to demographic and clinical charac-
teristics. Means, standard deviation and 95% confidence
interval were calculated for all variables. Antihyperten-
sive drugs by class (Hydrochlorothiazide, ACE-inhibi-
tors, Angiotensin type 2 receptor blockers, Beta-blockersand Calcium channel blockers) were entered as binary
values.
For the analysis of quantitative parameters, the t-test
and Mann–Whitney test were used to compare aspects
of hypertensive patients with or without changes in cog-
nitive function and control individuals. The chi-square
test and proportions were adopted for qualitative
variables.
Analysis of variance (ANOVA) was used to compare
the mean of the carotid intima thickness, central SBP
and Augmentation Index between the three groups.
Logistic regression, with the STATA 12.1 statistics pro-
gram (Stata Corp LP, College Station, Texas, USA), was
used to determine if independent variables can predict
the outcome, in this case CD (the dependent variable).
The independent variables were the clinical and demo-
graphic variables including, age, gender, BMI, blood
sugar levels, total cholesterol, LDL cholesterol, HDL
cholesterol, triglycerides, creatinine, estimated glomeru-
lar filtration rate, microalbuminuria, 24-hour urinary so-
dium excretion, systolic blood pressure, diastolic blood
pressure, pulse pressure, mean blood pressure, augmen-
tation index (Ai75), central systolic blood pressure
(CSBP) and carotid IMT. Statistical significance was set
for a p-value < 0.05.
Results
There were statistically significant differences between
the groups in respect to age (HCD, HNCD vs. CT - p-
value < 0.0001; HCD vs. HNCD - p-value = 0.0017) and
BMI (HCD vs. CT - p-value < 0.0001; HNCD vs. CT - p-
value < 0.0001). No significant differences were found
between the two hypertensive subgroups in relation to
the duration of hypertension (HCD = 15.03 ± 9.74 vs.
HNCD 15.73 ± 9.57 - p-value = 0.40) and in relation to
the use of different anti-hypertensive drug classes
(Table 1).
The mean values of SBP, DBP, MAP and PP in the
HCD and HNCD groups measured during outpatient
visits were all higher than in the CT group. There were
statistically significant differences for the SBP and PP of
the HCD and HNCD groups versus the CT group (p-
value < 0.001). There was no statistically significant dif-
ference for DBP and heart rate (HR) comparing the
three groups (Table 2).
The biochemical values of the three groups are
described in Table 3.
The results of the MMSE for the three groups (HCD,
HNCD and CT) expressed as means ± standard devi-
ation are summarized in Table 4. A significantly lower
MMSE score was found for the HCD group compared
to the HNCD and CT groups (Figure 1).
The logistic regression analysis of risk factors for pre-
dictive effect on CD in hypertensive patients (age,
Table 1 Demographic and anthropometric characteristics
of the HCD, HNCD and CT groups
HCD HNCD CT
Age (years) 63.22 ± 9.3* 55.75 ± 8.66* 44.56 ± 7.93
Gender: F/M 26/16 58/50 30/18
Height 1.62 ± 0.11 1.65 ± 0.09 1.63v0.24
weight 75.56 ± 15.95 80.69 ± 16.18 71.58v18.25
BMI (kg/m2) 29.04 ± 6.81* 29.57 ± 5.2* 25.83 ± 4.91
Duration HBP 15.03 ± 9.74 15.73 ± 9.57 -
Number of A-H 2.43 ± 0.97 2.35 ± 0.85
HCT 36 (86%) 85 (79%)
ACEI 22 (52%) 53 (49%)
ARB 15 (36%) 45 (42%)
BB 16 (38%) 40 (37%)
CCB 13 (31%) 31 (29%)
n 42 108 48
Values expressed as means ± standard deviation or n (%).
n number of individuals, HCD hypertensive with cognitive deficiency, HNCD
hypertensive without cognitive deficiency, CT controls, BMI body mass index,
M male, F female, HBP high blood pressure.
A-H Anti-hypertensive drugs, HCT Hydrochlorothiazide, ACEI Angiotensin
Converting Enzyme Inhibitor, ARB Angiotensin Type 2 Receptor Blocker, BB
beta blocker, CCB Calcium Chanel Blocker.
* p-value < 0.0001 HCD-HNCD vs. CT.
Table 3 Biochemical parameters of the HCD, HNCD and
CT groups
HCD HNCD CT
Glycemia (mg/dL) 106.7 ± 23.26 116.9 ± 42.71* 91.04 ± 25.62
Total cholesterol
(mg/dL)
186.9 ± 36.59 184.6 ± 38.62 201.9 ± 44.82#
LDL cholesterol
(mg/dL)
102.6 ± 30.71 96.62 ± 28.96 124.4 ± 34.94
HDL cholesterol
(mg/dL)
57.68 ± 12.59 51.16 ± 13.19 54.28 ± 14.37
Triglycerides (mg/dL) 159.5 ± 12.91 153.1 ± 138.2 121.1 ± 58.31
Creatinine (mg/dL) 1.08 ± 0.17 † 1.13 ± 0.28 † 0.76 ± 0.21
eGFR 70.14 ± 21.77 73.31 ± 22.65 98.16 ± 18.9
Microalbuminuria
mg/24 h
49.24 ± 72.76 64.60 ± 202.7 8.6 ± 13.8
Potassium (mEq/L) 4.27 ± 0.27 4.28 ± 0.42 4.24 ± 0.08
24 h Urinary Sodium
(mEq/24 h)
206.0 ± 72.83 ≠ 204.2 ± 80.82 ≠ 169.1 ± 55.23
n 41 108 48
Values expressed as means ± standard deviation.
n number of individuals, HCD hypertensive with cognitive deficiency, HNCD
hypertensive without cognitive deficiency, CT controls, LDL low-density
lipoprotein cholesterol fraction, HDL high-density lipoprotein cholesterol
fraction; eGFR estimated glomerular filtration rate.
* # † ≠ p-value < 0.0001.
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cholesterol, HDL cholesterol, LDL cholesterol, triglycer-
ides, creatinine, estimated glomerular filtration rate,
microalbuminuria, and 24-hour urinary sodium excre-
tion) showed that only age HDL cholesterol, LDL chol-
esterol, triglycerides and increased IMT were associated
with increased odds ratios (OR) in hypertensive patients
with declines in MMSE scores (Table 5 and Figure 2).
The results of carotid IMT measurement in the three
groups (HCD, HNCD and CT) are shown in Figure 3.
The HCD group had a significantly greater IMT com-
pared to the CT group (0.99 ± 0.2 mm versus 0.69 ±
0.1 mm, respectively; p-value < 0.0001). Similarly, there
was a statistically significant difference between theTable 2 Hemodynamic characteristics of the HCD, HNCD
and CT groups
HCD HNCD CT
SBP (mmHg) 132.9 ± 24.29* 128.4 ± 16.66† 115.4 ± 20.61
DBP (mmHg) 73.26 ± 15.24 73.65 ± 13.32 70.49 ± 13.25
MBP (mmHg) 93.13 ± 16.61 91.90 ± 13.12 85.44 ± 15.45
PP (mmHg) 59.61 ± 18.41* 54.75 ± 13.17† 44.96 ± 9.53
HR (bpm) 68.00 ± 13.1 71.91 ± 11.29 72.78 ± 11.08
n 42 108 48
Values expressed as means ± standard deviation.
n number of individuals, HCD hypertensive with cognitive deficiency, HNCD
hypertensive without cognitive deficiency, CT controls, SBP systolic blood
pressure, DBP diastolic blood pressure, MBP mean blood pressure, PP pulse
pressure, HR heart rate.
* p-value < 0.0001 HCD vs. CT; † p-value < 0.002 HNCD vs. CT.HNCD and CT groups (0.89 ± 0.2 mm vs. 0.69 ±
0.1 mm, respectively; p-value < 0.0001). On the other
hand, we also observed statistically significant differences
for the IMT between the HCD and HNCD groups (0.99
± 0.2 mm vs. 0.89 ± 0.2 mm, respectively; p-value =
0.0124).
Table 6 shows the CSBP and Augmentation Index
(Ai75) corrected for HR for the three groups (HCD,
HNCD and CT) and Figure 4 shows the results of the
measurement of the central SBP for the three groups
(HCD, HNCD and CT). The CSBP was significantly
higher for the HCD group compared to the CT group
(123.8 ± 3.91 mmHg vs. 105.5 ± 2.0 mmHg, respectively;
p-value < 0.0001). Similarly, there was a statistically sig-
nificant difference between the HNCD group and the
CT group (118.5 ± 1.58 mmHg vs. 105.5 ± 2.0 mmHg,
respectively; p-value < 0.0001). On the other hand, no
significant difference was observed for the CSBP be-
tween the HCD and HNCD groups (123.8 ± 3.91 mmHg
versus 118.5 ± 1.58 mmHg; p-value = 0.245).Table 4 Mini-Mental State Examination Score for the
HCD, HNCD and CT groups
Group Mean SD 95% CI
CT 27.77 4.4 26.46 - 28.08
HNCD 28.44 1.30 28.19 - 28.69
HCD 22.02 2.4 21.27 - 22.78
n number of individuals, HCD hypertensive with cognitive deficiency, HNCD
hypertensive without cognitive deficiency, CT controls SD standard deviation,
95% CI = 95% confidence interval.



















Figure 1 Assessment score of the Mini-Mental State
Examination for the CT, HNCD and HCD groups.
MMSE = Mini-Mental State Examination; CT = controls;
HNCD = arterial hypertension without cognitive deficiency;
HCD = arterial hypertension with cognitive deficiency.
Table 5 Logistic regression, Odds Ratio (OR) and 95%
Confidence Interval (CI) for cognitive dysfunction in
relation to cardiovascular risk factors
Odds Ratio SD p-value 95% CI
Age 1.113 0.406 0.048* 1.043 1.181
Gender 1.339 0.673 0.562 0.499 3.587
BMI 0.975 0.044 0.580 0.891 1.066
Glycemia 0.971 0.158 0.075 0.941 1.003
Total cholesterol 0.860 0.487 0.007* 0.769 0.901
LDL cholesterol 1.173 0.669 0.005* 1.049 1.312
HDL cholesterol 1.163 0.676 0.009* 1.038 1.304
Triglycerides 1.128 0.010 0.006* 1.067 1.148
Creatinine 0.245 0.322 0.284 0.189 3.206
eGFR 0.978 0.108 0.215 0.944 1.013
Microalbuminuria 1.003 0.003 0.174 0.999 1.019
24 h Urinary Sodium 1.004 0.004 0.303 0.996 1.013
SBP 1.203 0.270 0.409 0.775 1.868
DBP 0.628 0.427 0.495 0.165 2.385
PP 0.737 0.232 0.335 0.397 1.369
MBP 1.337 0.837 0.643 0.391 4.564
CSBP 1.006 0.382 0.858 0.934 1.072
Ai 75 1.021 0.255 0.392 0.972 1.072
IMT 1.128 0.002 0.041* 1.031 1.219
* p-value < 0.05.
BMI body mass index, LDL low-density lipoprotein cholesterol fraction, HDL
high-density lipoprotein cholesterol fraction, eGFR estimated glomerular
filtration rate, SBP systolic blood pressure, DBP diastolic blood pressure, PP
pulse pressure, MBP mean blood pressure, CSBP central systolic blood
pressure, Ai 75 augmentation index at 75 beats per minute, IMT carotid intima
media thickness.
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spect to the Augmentation Index (corrected for HR) be-
tween the three groups (HCD, HNCD and CT).
Discussion
The main results of this study show: 1) morphological
changes characterized by an increased carotid IMT and
functional changes qualified as an increase in central
SBP in hypertensive patients with CD; 2) Among the risk
factors for the development of CD, the age, HDL choles-
terol, LDL cholesterol, triglycerides and increased IMT
were significantly associated with a drop in MMSE
scores in hypertensive patients.
Several factors have been associated with loss of cogni-
tive function in older adults. According to many studies
the educational level is considered to be one of the most
important determinants [17,59,60] with less well edu-
cated individuals being more likely to have CD. Age has
also been linked directly to a loss of cognitive function
[61-65]. Other factors have also been mentioned in stud-
ies such as being female [66], smoking [67,68], athero-
sclerosis [69,70], diabetes mellitus [17,71,72], family
history of dementia [73] and low-income [17,74].
In this study, the atherosclerotic profile, confirmed by
increases in LDL cholesterol, triglycerides and subclin-
ical atherosclerosis characterized by increased carotid
IMT were associated with higher ORs for cognitive dys-
function in hypertensive patients independently of the
pharmacological antihypertensive treatment and the
other risk factors for cardiovascular disease.
Elevation of LDL cholesterol levels increase the risk of
cognitive dysfunction by 17% in hypertensive patients in
agreement with a few previous reports that showed
negative effects of the atherosclerotic lipid profile on the
cognitive function in adults [30,75].
On the other hand, epidemiological studies in Rotter-
dam, Netherlands, demonstrated a significant associ-
ation between various cardiovascular risk factors
including hypertension [76], cerebral white matter lesions
and worse performance in neuropsychometric tests
[59,60,75,77,78]. Additionally, Ikeda et al. [79], in an
analysis of 76 untreated hypertensive patients, 173 trea-
ted hypertensive patients and 69 normotensive indivi-
duals, showed that the non-treated hypertensive subjects
had a higher prevalence of asymptomatic cerebral lacu-
nae at computed tomography compared to normotensive
individuals. In this study, the severity and duration of
hypertension had a direct correlation with cerebrovascu-
lar complications. Studies with large samples showed
comparable findings. Liao et al. [79], for example, stud-
ied 1920 subjects using magnetic resonance imaging.
Hypertension, smoking and age were associated with a
higher prevalence of cerebral white matter lesions al-
though the authors did not investigate possible
Logistic regresion for cognitive dysfunction



















Odds Ratio (IC 95%)
Figure 2 Logistic regression for event cognitive dysfunction in hypertensive patients. Odds Ratio (OR) and Confidence Interval 95%
(CI 95%). BMI – body mass index; LDL - low-density lipoprotein cholesterol fraction; HDL - high-density lipoprotein cholesterol fraction;
eGFR – estimated glomerular filtration rate; SBP = systolic blood pressure; DBP = diastolic blood pressure; PP = pulse pressure; MBP =mean blood
pressure; CSBP = central systolic blood pressure; IMT = carotid intima-media thickness.
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epidemiological studies also showed positive results in
the analysis of this association. Starr et al. [31] in a
cross-sectional study of 598 elderly, identified a lower
mean MMSE score for individuals with high SBPCarotid intim













Figure 3 Evaluation of the carotid intima-media thickness for the CT,
CT – controls; HNCD = arterial hypertension without cognitive deficiency; Hcompared to individuals with normal or low SBPs.
Prince et al. [32] performed a case–control study in a
clinical trial designed to investigate hypertension treat-
ment in the elderly; a subsample of 50 dementia cases
and 223 controls was selected. The study showed thata-media thickness




HNCD and HCD groups. IMT = carotid intima-media thickness;
CD = arterial hypertension with cognitive deficiency.
Table 6 Central systolic blood pressure and
Augmentation Index with correction for a mean heart
rate of 75 beats per minute
Group Mean SD 95% CI
CT CSBP (mmHg) 103.6 18.99 80.93 - 90.50
Ai 75 (mmHg) 85.11 15.96 80.48 - 89.75
HNCD CSBP (mmHg) 118.8 15.99 15.6 - 121.9
Ai 75 (mmHg) 88.85 9.77 86.93 - 90.77
HCD CSBP (mmHg) 120.9 28.56 111.5 -130.3
Ai 75 (mmHg) 89.04 17.15 86.28 - 94.68
HCD hypertensive with cognitive deficiency, HNCD hypertensive without
cognitive deficiency, CT controls, CSBP central systolic blood pressure,
Ai 75 Augmentation Index at 75 beats per minute.
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identified as a risk factor for dementia. Launer et al. [80]
identified an 8% increase in the risk of CD for each
10 mmHg increase in SBP among 3,735 Japanese Ameri-
cans. Freidl et al. [81], studying a sample of 1927 healthy
elderly in the United States, found among the 16 socio-
demographic, environmental and behavioral factors
investigated that only age and the presence of hyperten-
sion were associated with impaired cognitive perform-
ance. Our study also showed that age was significantly
associated with a decline in the MMSE scores irrespect-
ive of BP, biochemical markers and anthropometric
variables.
Scuteri et al. demonstrated the role of vascular health
in determining cognitive function in older individuals



















Figure 4 Central systolic blood pressure for the HCD, HNCD and CT g
hypertension with cognitive deficiency; HNCD = arterial hypertension withoarterial stiffness was a strong predictor of loss of cogni-
tive function independent of age, gender, education and
traditional cardiovascular risk factors [82].
Similarly, vascular remodeling detected by estimating
the carotid IMT has been linked to increased risk of car-
diovascular, coronary and brain events; this represents
an important step in carotid plaque formation and pro-
gression and is a characteristic marker of atherosclerosis.
[83-85]. Of the different pathophysiological explanations,
an association between increased IMT and greater pres-
sure variations found in hypertensive patients with vas-
cular remodeling has been described [86]. On the other
hand, Forman et al. reported that endothelial-dependent
and endothelial-independent vascular responsiveness
was correlated with neurocognitive performance among
older cardiovascular disease patients, particularly in re-
spect to the attention-executive domain. [87]
With clinical observation, there is a non-consensual
understanding that the different forms of hypertension
and the results of complications in target organs, related
to stiffening of the vascular wall and atherosclerotic
plaque formation among other things, are associated to
micro- and macro-infarcts of the white substance and is
an important causal agent of CD [60,76,88,89]. However,
there are few studies in the literature on the association
of vascular structural alterations and CD. The results of
the current study demonstrate that structural alterations
characterized by increased carotid IMT are significantly
associated with hypertension in the hypertensive group
with CD when compared to hypertensive patientsHNCD CT
c blood pressure
D and CT groups
P < 0,0001
,0001
roups. CSBP = central systolic blood pressure; HCD = arterial
ut cognitive deficiency and CT = controls.
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itional information to conventional risk factors for cog-
nitive dysfunction.
There are also few publications in the literature
regarding functional hemodynamic changes in hyperten-
sive patients with CD. Our study shows that hyperten-
sive patients, both with and without CD, have
significantly higher CSBP compared to the CT group.
However, there was no statistically significant difference
in the CSBPs of hypertensive patients with and without
CD.
There were no statistically significant differences for
the Augmentation Index corrected for HR between the
three groups (HCD, HNCD and CT).
Several hypotheses may explain the absence of signifi-
cant differences between hypertensive patients with and
without CD. Antihypertensive therapy using renin-
angiotensin-aldosterone blockers and calcium channel
blockers interferes in the hemodynamics of arterial, cen-
tral and peripheral BP thus favoring a reduction in the
height of the central pressure wave, thereby reducing the
Augmentation Index and the central SBP. However, this
does not invalidate the important structural finding
represented by the main alteration found in the hyper-
tensive group with CD; vascular remodeling character-
ized by increased carotid IMT.
Potentially confounding effects of antihypertensive
therapy on vascular structural and hemodynamic
changes may influence cognitive function. In this study
the antihypertensive medication did not influence the
results (specifically beta-blockers, ACE inhibitors, ARBs
and calcium channel blockers).
This study has some limitations: the results are based
on a cross-sectional study and so a longitudinal ap-
proach is needed to confirm the influence of age on
results. Additionally we cannot exclude the influence of
genetic factors on the pathophysiology of CD in hyper-
tensive patients. However, new opportunities for struc-
tural and functional hemodynamic evaluations are
presented for prospective studies on hypertensive
patients who have risk factors for CD which may
reinforce the importance of achieving the goal in the
treatment of hypercholesterolemia in high-risk patients
to prevent CD.
Conclusions
Hypertensive patients with CD have vascular morpho-
logical changes characterized by increased carotid IMT,
enhanced atherosclerotic lipid profile and impaired
hemodynamic functional manifested by elevated central
systolic blood pressure.
Competing interests
The authors declare that they have no competing interests.Authors’ contributions
EMD: participated in the study design, clinical assessment of participants,
ultrasound examinations, participated in the discussion of the results and
helped to write the manuscript. LTG Jr: participated of the clinical
assessment of participants, measurement of the central blood pressure and
in the discussion of the results.DDM: participated in the collection of clinical
data, the blinded measurement of the ultrasound examinations and helped
to draft the manuscript. CM: participated in data collection, assessments of
peripheral blood pressure and the central blood pressure examination and
elaborated the figures. HM Jr: participated of the study design, assessment of
the methodology, blinded evaluation of ultrasound examinations and helped
with the final discussion. JFVM: participated in the clinical assessment of
patients and participated in the discussion of the results. JCYT: participated
of the study design, methodological assessment, statistical review, discussion
of the results and helped to write the manuscript, corrected the final version
in English and submitted the article. All authors read and approved the final
manuscript.
Author details
1Hypertension Clinic, Department of Internal Medicine, State Medical School
of São José do Rio Preto (FAMERP), Rua: Las Vegas 200, São José do Rio
Preto, SP CEP 15093-010, Brazil. 2Cardiovascular Pharmacology Laboratory,
Faculty of Medical Sciences, State University of Campinas (UNICAMP),
Campinas, SP CEP 13414-093, Brazil.
Received: 13 December 2011 Accepted: 18 September 2012
Published: 18 October 2012
References
1. Kannel WB: Office assessment of coronary candidates and risk factor
insights from the Framingham study. J Hypertens Suppl 1991, 9(7):S13–S19.
2. Kannel WB: Hypertension as a risk factor for cardiac events–
epidemiologic results of long-term studies. J Cardiovasc Pharmacol 1993,
21(Suppl 2):S27–S37.
3. Kannel WB: Framingham study insights into hypertensive risk of
cardiovascular disease. Hypertens Res 1995, 18(3):181–196.
4. Kannel WB, Levy D, Cupples LA: Left ventricular hypertrophy and risk of
cardiac failure: insights from the Framingham Study. J Cardiovasc
Pharmacol 1987, 10(Suppl 6):S135–S140.
5. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK: The progression from
hypertension to congestive heart failure. JAMA 1996, 275(20):1557–1562.
6. Haider AW, Larson MG, Franklin SS, Levy D: Systolic blood pressure,
diastolic blood pressure, and pulse pressure as predictors of risk for
congestive heart failure in the Framingham Heart Study. Ann Intern Med
2003, 138(1):10–16.
7. Wilson SK, Hutchins GM: Aortic dissecting aneurysms: causative factors in
204 subjects. Arch Pathol Lab Med 1982, 106(4):175–180.
8. Crawford ES: The diagnosis and management of aortic dissection.
JAMA 1990, 264(19):2537–2541.
9. Coard KC, Didier M: Aortic dissection. An autopsy experience. West Indian
Med J 1990, 39(2):80–85.
10. Veriava Y, du Toit E, Lawley CG, Milne FJ, Reinach SG: Hypertension as a
cause of end-stage renal failure in South Africa. J Hum Hypertens 1990,
4(4):379–383.
11. Mailloux LU: Hypertension in chronic renal failure and ESRD: prevalence,
pathophysiology, and outcomes. Semin Nephrol 2001, 21(2):146–156.
12. Zoccali C, Mallamaci F, Tripepi G: Hypertension as a cardiovascular risk
factor in end-stage renal failure. Curr Hypertens Rep 2002, 4(5):381–386.
13. Karthikeyan VJ, Lip GY: Peripheral artery disease and hypertension: the
relation between ankle-brachial index and mortality. J Hum Hypertens
2007, 21(10):762–765.
14. Kannel WB: Blood pressure as a cardiovascular risk factor: prevention and
treatment. JAMA 1996, 275(20):1571–1576.
15. Kannel WB: Historic perspectives on the relative contributions of diastolic
and systolic blood pressure elevation to cardiovascular risk profile.
Am Heart J 1999, 138(3 Pt 2):205–210.
16. Plouin PF, Rossignol P, Bobrie G: Hypertension in the elderly. Bull Acad Natl
Med 2006, 190(4–5):793–805. discussion 6, 73–6.
17. Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H,
et al: Canadian Consensus Conference on Dementia: a physician’s guide
to using the recommendations. CMAJ 1999, 160(12):1738–1742.
Dias et al. Cardiovascular Ultrasound 2012, 10:41 Page 10 of 11
http://www.cardiovascularultrasound.com/content/10/1/4118. Fritsch T, McClendon MJ, Smyth KA, Lerner AJ, Friedland RP, Larsen JD:
Cognitive functioning in healthy aging: the role of reserve and lifestyle
factors early in life. Gerontologist 2007, 47(3):307–322.
19. Farmer ME, White LR, Abbott RD, Kittner SJ, Kaplan E, Wolz MM, et al: Blood
pressure and cognitive performance. The Framingham Study. Am J
Epidemiol 1987, 126(6):1103–1114.
20. Duron E, Hanon O: Hypertension, cognitive decline and dementia.
Arch Cardiovasc Dis 2008, 101(3):181–189.
21. Scheinberg P: Dementia due to vascular disease–a multifactorial disorder.
Stroke 1988, 19(10):1291–1299.
22. Dozono K, Ishii N, Nishihara Y, Horie A: An autopsy study of the incidence
of lacunes in relation to age, hypertension, and arteriosclerosis. Stroke
1991, 22(8):993–996.
23. Chui HC: Subcortical ischemic vascular dementia. Neurol Clin 2007,
25(3):717–740. vi.
24. Obisesan TO: Hypertension and cognitive function. Clin Geriatr Med 2009,
25(2):259–288.
25. Prins ND, van Dijk EJ, den Heijer T, Vermeer SE, Koudstaal PJ, Oudkerk M,
et al: Cerebral white matter lesions and the risk of dementia. Arch Neurol
2004, 61(10):1531–1534.
26. Gunstad J, Cohen RA, Tate DF, Paul RH, Poppas A, Hoth K, et al: Blood
pressure variability and white matter hyperintensities in older adults
with cardiovascular disease. Blood Press 2005, 14(6):353–358.
27. Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S, et al:
Association of white matter hyperintensity volume with decreased
cognitive functioning: the Framingham Heart Study. Arch Neurol 2006,
63(2):246–250.
28. Debette S, Bombois S, Bruandet A, Delbeuck X, Lepoittevin S, Delmaire C,
et al: Subcortical hyperintensities are associated with cognitive decline in
patients with mild cognitive impairment. Stroke 2007, 38(11):2924–2930.
29. Chen F, Suzuki Y, Nagai N, Jin L, Yu J, Wang H, et al: Rodent stroke induced
by photochemical occlusion of proximal middle cerebral artery:
evolution monitored with MR imaging and histopathology. Eur J Radiol
2007, 63(1):68–75.
30. Duron E, Hanon O: Vascular risk factors, cognitive decline, and dementia.
Vasc Health Risk Manag 2008, 4(2):363–381.
31. Starr JM, Whalley LJ, Inch S, Shering PA: Blood pressure and cognitive
function in healthy old people. J Am Geriatr Soc 1993, 41(7):753–756.
32. Prince M, Cullen M, Mann A: Risk factors for Alzheimer’s disease and
dementia: a case–control study based on the MRC elderly hypertension
trial. Neurology 1994, 44(1):97–104.
33. in’t Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM:
Antihypertensive drugs and incidence of dementia: the Rotterdam
Study. Neurobiol Aging 2001, 22(3):407–412.
34. Efimova N, Chernov VI, Efimova I, Afanas’eva NL, Lishmanov IB: Cognitive
dysfunction and brain perfusion in patients with arterial hypertension:
possibilities of pharmacological therapy. Zh Nevrol Psikhiatr Im S S
Korsakova 2008, 108(11):10–15.
35. Elias MF, Wolf PA, D’Agostino RB, Cobb J, White LR: Untreated blood
pressure level is inversely related to cognitive functioning: the
Framingham Study. Am J Epidemiol 1993, 138(6):353–364.
36. Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, et al:
The prevention of dementia with antihypertensive treatment: new
evidence from the Systolic Hypertension in Europe (Syst-Eur) study.
Arch Intern Med 2002, 162(18):2046–2052.
37. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S,
et al: Effects of blood pressure lowering with perindopril and
indapamide therapy on dementia and cognitive decline in patients with
cerebrovascular disease. Arch Intern Med 2003, 163(9):1069–1075.
38. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al: The
Study on Cognition and Prognosis in the Elderly (SCOPE): principal
results of a randomized double-blind intervention trial. J Hypertens 2003,
21(5):875–886.
39. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al:
The Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7
report. JAMA 2003, 289(19):2560–2572.
40. Al-Azzam SI, Najjar RB, Khader YS: Awareness of physicians in Jordan
about the treatment of high blood pressure according to the seventh
report of the Joint National Committee (JNC VII). Eur J Cardiovasc Nurs
2007, 6(3):223–232.41. Bertolucci PH, Brucki SM, Campacci SR, Juliano Y: The Mini-Mental State
Examination in a general population: impact of educational status.
Arq Neuropsiquiatr 1994, 52(1):1–7.
42. Brucki SM, Nitrini R, Caramelli P, Bertolucci PH, Okamoto IH: Suggestions
for utilization of the mini-mental state examination in Brazil.
Arq Neuropsiquiatr 2003, 61(3B):777–781.
43. Brucki SM, Rocha MS: Category fluency test: effects of age, gender and
education on total scores, clustering and switching in Brazilian
Portuguese-speaking subjects. Braz J Med Biol Res 2004, 37(12):1771–1777.
44. Cullen B, O’Neill B, Evans JJ, Coen RF, Lawlor BA: A review of screening
tests for cognitive impairment. J Neurol Neurosurg Psychiatry 2007,
78(8):790–799.
45. Ladeira RB, Diniz BS, Nunes PV, Forlenza OV: Combining cognitive
screening tests for the evaluation of mild cognitive impairment in the
elderly. Clinics (Sao Paulo) 2009, 64(10):967–973.
46. Haubois G, Annweiler C, Launay C, Fantino B, de Decker L, Allali G, et al:
Development of a short form of Mini-Mental State Examination for the
screening of dementia in older adults with a memory complaint: a case
control study. BMC Geriatr 2011, 11:59.
47. Redberg RF, Vogel RA, Criqui MH, Herrington DM, Lima JA, Roman MJ: 34th
Bethesda Conference: Task force #3–What is the spectrum of current
and emerging techniques for the noninvasive measurement of
atherosclerosis? J Am Coll Cardiol 2003, 41(11):1886–1898.
48. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al: Use of
carotid ultrasound to identify subclinical vascular disease and evaluate
cardiovascular disease risk: a consensus statement from the American
Society of Echocardiography Carotid Intima-Media Thickness Task Force.
Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr
2008, 21(2):89–90.
49. Yugar-Toledo JC, Bonalume Tacito LH, Ferreira-Melo SE, Sousa W,
Consolin-Colombo F, Irigoyen MC, et al: Low-renin (volume dependent)
mild-hypertensive patients have impaired flow-mediated and
glyceryl-trinitrate stimulated vascular reactivity. Circ J 2005,
69(11):1380–1385.
50. Lonn E, Suppl A: Use of carotid ultrasound to stratify risk. Can J Cardiol
2001, Suppl A:22A–25A.
51. Nelson MR, Stepanek J, Cevette M, Covalciuc M, Hurst RT, Tajik AJ:
Noninvasive measurement of central vascular pressures with arterial
tonometry: clinical revival of the pulse pressure waveform? Mayo Clin
Proc 2010, 85(5):460–472.
52. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al: Central
pressure more strongly relates to vascular disease and outcome than
does brachial pressure: the Strong Heart Study. Hypertension 2007,
50(1):197–203.
53. Agabiti-Rosei E, Mancia G, O’Rourke MF, Roman MJ, Safar ME, Smulyan H,
et al: Central blood pressure measurements and antihypertensive
therapy: a consensus document. Hypertension 2007, 50(1):154–160.
54. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D,
et al: Expert consensus document on arterial stiffness: methodological
issues and clinical applications. Eur Heart J 2006, 27(21):2588–2605.
55. O’Rourke MF, Adji A: An updated clinical primer on large artery
mechanics: implications of pulse waveform analysis and arterial
tonometry. Curr Opin Cardiol 2005, 20(4):275–281.
56. O’Rourke MF, Seward JB: Central arterial pressure and arterial pressure
pulse: new views entering the second century after Korotkov. Mayo Clin
Proc 2006, 81(8):1057–1068.
57. Lowe A, Harrison W, El-Aklouk E, Ruygrok P, Al-Jumaily AM: Non-invasive
model-based estimation of aortic pulse pressure using suprasystolic
brachial pressure waveforms. J Biomech 2009, 42(13):2111–2115.
58. Avolio AP, Butlin M, Walsh A: Arterial blood pressure measurement and
pulse wave analysis–their role in enhancing cardiovascular assessment.
Physiol Meas 2010, 31(1):R1–R47.
59. Inouye SK, Albert MS, Mohs R, Sun K, Berkman LF: Cognitive performance
in a high-functioning community-dwelling elderly population. J Gerontol
1993, 48(4):M146–M151.
60. Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafstrom M, Holmen K, et al:
Prevalence of Alzheimer’s disease and other dementias in an elderly
urban population: relationship with age, sex, and education. Neurology
1991, 41(12):1886–1892.
61. Sulkava R, Erkinjuntti T, Palo J: Head injuries in Alzheimer’s disease and
vascular dementia. Neurology 1985, 35(12):1804.
Dias et al. Cardiovascular Ultrasound 2012, 10:41 Page 11 of 11
http://www.cardiovascularultrasound.com/content/10/1/4162. Jin H, Zhang MY, Qu OY, Wang ZY, Salmon DP, Katzman R, et al:
Cross-cultural studies of dementia: use of a Chinese version of the
Blessed-Roth Information-Memory-Concentration test in a Shanghai
dementia survey. Psychol Aging 1989, 4(4):471–479.
63. Katzman DA: Medical education in the United States: a century of
change. JAMA 1989, 261(13):1975–1978.
64. Katzman R, Aronson M, Fuld P, Kawas C, Brown T, Morgenstern H, et al:
Development of dementing illnesses in an 80-year-old volunteer cohort.
Ann Neurol 1989, 25(4):317–324.
65. Berkman LF: The association between educational attainment and
mental status examinations: of etiologic significance for senile
dementias or not? J Chronic Dis 1986, 39(3):171–175.
66. Kokmen E, Ozsarfati Y, Beard CM, O’Brien PC, Rocca WA: Impact of referral
bias on clinical and epidemiological studies of Alzheimer's disease. J Clin
Epidemiol 1996, 49(1):79–83.
67. Petrova M, Prokopenko S, Pronina E, Mozheyko E: Diabetes type 2,
hypertension and cognitive dysfunction in middle age women. J Neurol
Sci 2010, 299(1–2):39–41.
68. Shaji S, Promodu K, Abraham T, Roy KJ, Verghese A: An epidemiological
study of dementia in a rural community in Kerala, India. Br J Psychiatry
1996, 168(6):745–749.
69. Tangalos EG, Smith GE, Ivnik RJ, Petersen RC, Kokmen E, Kurland LT, et al:
The Mini-Mental State Examination in general medical practice: clinical
utility and acceptance. Mayo Clin Proc 1996, 71(9):829–837.
70. Umegaki H: Pathophysiology of cognitive dysfunction in older people
with type 2 diabetes: vascular changes or neurodegeneration?
Age Ageing 2010, 39(1):8–10.
71. Preobrazhenskaia IS, Iakhno NN: [Cognitive dysfunction in elderly patients:
diagnosis and treatment]. Zh Nevrol Psikhiatr Im S S Korsakova 2006,
106(11):33–38.
72. Patterson CJ, Gauthier S, Bergman H, Cohen CA, Feightner JW, Feldman H,
et al: The recognition, assessment and management of dementing
disorders: conclusions from the Canadian Consensus Conference on
Dementia. CMAJ 1999, 160(12 Suppl):S1–S15.
73. Inouye SK, Acampora D, Miller RL, Fulmer T, Hurst LD, Cooney LM Jr: The
Yale Geriatric Care Program: a model of care to prevent functional
decline in hospitalized elderly patients. J Am Geriatr Soc 1993,
41(12):1345–1352.
74. Chertkow H: Diagnosis and treatment of dementia: introduction.
Introducing a series based on the Third Canadian Consensus Conference
on the Diagnosis and Treatment of Dementia. CMAJ 2008, 178(3):316–321.
75. Ikeda N, Kogame N, Iijima R, Nakamura M, Sugi K: Carotid artery intima-
media thickness and plaque score can predict the SYNTAX score. Eur
Heart J 2012, 33(1):113–119.
76. Breteler MM, van Amerongen NM, van Swieten JC, Claus JJ, Grobbee DE,
van Gijn J, et al: Cognitive correlates of ventricular enlargement and
cerebral white matter lesions on magnetic resonance imaging. The
Rotterdam Study. Stroke 1994, 25(6):1109–1115.
77. Crum RM, Anthony JC, Bassett SS, Folstein MF: Population-based norms
for the Mini-Mental State Examination by age and educational level.
JAMA 1993, 269(18):2386–2391.
78. Brayne C, Beardsall L: Estimation of verbal intelligence in an elderly
community: an epidemiological study using NART. Br J Clin Psychol 1990,
29(Pt 2):217–223.
79. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, et al: The prevalence and
severity of white matter lesions, their relationship with age, ethnicity,
gender, and cardiovascular disease risk factors: the ARIC Study.
Neuroepidemiology 1997, 16(3):149–162.
80. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ: The association
between midlife blood pressure levels and late-life cognitive function.
The Honolulu-Asia Aging Study. JAMA 1995, 274(23):1846–1851.
81. Freidl W, Schmidt R, Stronegger WJ, Irmler A, Reinhart B, Koch M: Mini
mental state examination: influence of sociodemographic,
environmental and behavioral factors and vascular risk factors. J Clin
Epidemiol 1996, 49(1):73–78.
82. Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati AM, Volpe M: Arterial
stiffness as an independent predictor of longitudinal changes in
cognitive function in the older individual. J Hypertens 2007,
25(5):1035–1040.
83. Baldassarre D, Tremoli E, Amato M, Veglia F, Bondioli A, Sirtori CR:
Reproducibility validation study comparing analog and digital imagingtechnologies for the measurement of intima-media thickness. Stroke
2000, 31(5):1104–1110.
84. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM:
Incidence, risk, and case fatality of first ever stroke in the elderly
population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2003,
74(3):317–321.
85. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J: Intima-media
thickness: a new tool for diagnosis and treatment of cardiovascular risk.
J Hypertens 2002, 20(2):159–169.
86. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, et al: Relation
between blood pressure variability and carotid artery damage in
hypertension: baseline data from the European Lacidipine Study on
Atherosclerosis (ELSA). J Hypertens 2001, 19(11):1981–1989.
87. Forman DE, Cohen RA, Hoth KF, Haley AP, Poppas A, Moser DJ, et al:
Vascular Health and Cognitive Function in Older Adults with
Cardiovascular Disease. Artery Res 2008, 2(1):35–43.
88. Desmond DW, Tatemichi TK, Paik M, Stern Y: Risk factors for
cerebrovascular disease as correlates of cognitive function in a
stroke-free cohort. Arch Neurol 1993, 50(2):162–166.
89. Kokmen E, Whisnant JP, O’Fallon WM, Chu CP, Beard CM: Dementia after
ischemic stroke: a population-based study in Rochester, Minnesota
(1960–1984). Neurology 1996, 46(1):154–159.
doi:10.1186/1476-7120-10-41
Cite this article as: Dias et al.: Carotid intima-media thickness is
associated with cognitive deficiency in hypertensive patients with
elevated central systolic blood pressure. Cardiovascular Ultrasound 2012
10:41.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
